JS

Jaya Sood

Active Director Director DIN 09192938
DIN 09192938 First appointment Jun 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jun 2021
Shareholding value Locked Premium profile

About Jaya Sood

Jaya Sood has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Caveat Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09192938
Primary Designation Director
First Appointment 03 Jun 2021
Oldest Company Age 19 yrs

Current companies

Company Designation Appointment Founded Status
Caveat Pharma Private Limited U24119PB2007PTC031229
Director 03 Jun 2021 2007 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Caveat Pharma Private Limited
Premium access

Shareholding and investment profile for Jaya Sood

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaya Sood

Jaya Sood has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Caveat Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Jaya Sood is associated with 1 company as Director.

Jaya Sood has expertise in General Business.

Jaya Sood has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available